NCT07517198 2026-04-08Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsExscientia AI LimitedPhase 1 Recruiting40 enrolled
NCT01460134 2018-01-31A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCelldex TherapeuticsPhase 1 Completed90 enrolled